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The serine/threonine kinase LKB1 has a conserved role in Drosophila and nematodes to
co-ordinate cell metabolism. During T lymphocyte development in the thymus, progeni-
tors need to synchronize increased metabolism with the onset of proliferation and
differentiation to ensure that they can meet the energy requirements for development.
The present study explores the role of LKB1 in this process and shows that loss of LKB1
prevents thymocyte differentiation and the production of peripheral T lymphocytes. We
ﬁnd that LKB1 is required for several key metabolic processes in T-cell progenitors. For
example, LKB1 controls expression of CD98, a key subunit of the L-system aa transporter
and is also required for the pre-TCR to induce and sustain the regulated phosphorylation
of the ribosomal S6 subunit, a key regulator of protein synthesis. In the absence of LKB1
TCR-b-selected thymocytes failed to proliferate and did not survive. LBK1 was also
required for survival and proliferation of peripheral T cells. These data thus reveal a
conserved and essential role for LKB1 in the proliferative responses of both thymocytes
and mature T cells.
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Introduction
T-cell proliferation and differentiation in the thymus and the
periphery are regulated by the pre-TCR, the mature TCR,
cytokines and chemokines [1–3]. These stimuli are linked via
tyrosine kinases to a diverse network of serine/threonine kinases
that regulate the key checkpoints of T-cell proliferation and
differentiation [4–6]. T-cell expansion in the thymus is an energy-
demanding process that only proceeds when extra cellular signals
from Ag receptors, cytokines and stromal cells stimulate sufﬁcient
cellular energy production and nutrient uptake to satisfy the
biosynthetic demands of the activated T cell [7–9]. For example,
during T-cell development in the thymus there is rapid
proliferative expansion of TCR-b selected T-cell progenitors [3].
To meet the increased energy demands of these proliferating
cells, the pre-TCR and Notch induce and then maintain cell
surface expression of nutrient receptors such as aa transporters
and transferrin receptor and also increase the expression of the
glucose transporter. These increases in glucose metabolism and
aa uptake are essential for T-cell development in the thymus. For
example, the serine/threonine kinase phosphoinositide depen-
dent kinase 1 (PDK1) and its substrates protein kinase Ba (PKBa),
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thymocytes. T-cell progenitors that do not express PDK1 or that
lack expression of PKB isoforms fail to express these nutrient
receptors and fail to develop because they cannot meet the
metabolic demands of thymus development [7, 8, 10, 11].
One other serine/threonine kinase that can regulate cellular
responses to energy stress is LKB1 (or serine/threonine kinase 11
-STK11) [12]. This is an evolutionarily conserved kinase: Par4,
the Caenorhabditis elegans ortholog, is one of the six ‘‘partition-
ing’’ molecules that control zygote polarity [13] in Drosophila.
The LKB1 ortholog is required to synchronize cellular energy
checkpoints and cell division [14, 15]. The Drosophila LKB1
homologue is thus essential for mitotic spindle formation,
for the establishment of cell polarity and controlling the
asymmetric division of stem cells [16]. LKB1 also has essential
functions in mice as LKB1 deletion causes problems with
vascular and neural development that result in embryonic leth-
ality at E10-11 [17]. In humans the importance of LKB1 is
highlighted by the fact that it is mutated in a high proportion of
Peutz-Jeghers syndrome patients: Peutz-Jeghers syndrome is
associated with the development of benign hamartomas and an
increased risk of malignant tumor formation [18–20]. LKB1 is
important because it phosphorylates critical activating residues in
the catalytic domains of multiple members of the AMP-activated
protein kinase (AMPK) family including the a1 and a2 isoforms of
AMPK and NUAK1–2, BRSK1-2, QIK, QSK, Salt-inducible kinase
(SIK), MELK and MARK1–4 kinases [21]. The AMPKa1 and a2
are phosphorylated and activated by LKB1 in response to
increases in cellular AMP:ATP ratio. AMPK then act to restore
energy balance in a cell by inhibiting ATP consuming processes
and stimulating ATP generating pathways [22]. SIK and MARK2
also regulate cellular metabolic responses in different tissues
leading to a model whereby LKB1 acts to regulate the energy
status of the cell [23–25]. The signiﬁcance of LKB1 in energy
checkpoints is illustrated by the fact that loss of LKB1 in ﬁbro-
blasts and in the pancreas is associated with apoptosis in response
to energy stress [26, 27]. There is also evidence that LKB1
controls the induction of autophagy in response to energy
deprivation and sensitizes epithelial cells to c-myc-induced
apoptosis [28, 29].
The role of LKB1 and AMPK family kinases in lymphocytes is
not known but is topical because of the increasing awareness that
energy control and the regulation of asymmetric cell division may
control T lymphocyte fate [11, 30]. In mature T cells, the a1
AMPK isoform is expressed and is activated by TCR triggering via
calcium/calmodulin dependent kinase kinases and by energy
stress, presumably via LKB1 [31]. AMPK a1-null T cells have
increased sensitivity to energy stress but can mount apparently
normal immune responses [32]. There are, however, immune
defects in mice that lack expression of another AMPK family
kinase, MARK2. T cells lacking expression of MARK2 are hyper-
responsive to TCR triggering with increased cytokine production
and MARK2-null mice develop autoimmune disease, indicating
that MARK2 is required for immune homeostasis [33]. Interest-
ingly, neither AMPka1- nor MARK2-null mice have defects in
T-cell development in the thymus [32, 33]. This could indicate
that AMPK family kinases are physiologically irrelevant for T-cell
development but it is perhaps more likely that there is redun-
dancy between different AMPK family members. One experi-
mental strategy that circumvents problems caused by the
existence of multiple redundant kinases is to delete a rate-limit-
ing speciﬁc upstream regulator. In the context of the AMPK family
the obvious candidate is LKB1, a ‘‘master kinase’’ that phos-
phorylates and activates multiple AMPK family kinases [21].
Accordingly, the present study reports the impact of T-lineage-
speciﬁc deletion of LKB1 and shows that LKB1 has essential
functions for the development of TCR-b selected T-cell progeni-
tors. LBK1 was also required for survival and proliferation of
peripheral T cells revealing that AMPK family kinases control
proliferative checkpoints in thymocyte differentiation and in
peripheral T cells.
Results
Deletion of LKB1 prevents T-cell development
The objective of the present study was to explore the role of LKB1
in T lymphocytes. Mice with ﬂoxed LKB1 exons 4–7 on both
alleles (LKB1
ﬂ/ﬂ) [34] were backcrossed with mice expressing Cre
recombinase under the control of the proximal p56lck proximal
promoter (Lck-Cre
1), which induces Cre expression in T-cell
progenitors in the thymus [35]. The LckCre
1LKB1
ﬂ/ﬂ mice were
viable, although they had very small thymi (Fig. 1A) that lacked
the normal cortical/medullar architecture (data not shown).
These small LckCre
1 LKB1
ﬂ/ﬂ thymi contained greatly reduced
numbers of thymocytes compared to LckCre
1LKB1
1/1 controls
(Fig. 1B). To determine which stages of thymocyte development
were sensitive to LKB1 loss, LckCre
1LKB1
ﬂ/ﬂ thymi were
analyzed for expression of the major histocompatibility complex
(MHC) receptors CD4 and CD8. Early T-cell progenitors are
double negative (DN) for CD4 and CD8. DN progenitors undergo
TCR-b locus rearrangements to produce a TCR-b polypeptide that
permits surface expression of the pre-TCR complex. The pre-TCR
then supports survival and directs rapid clonal expansion along
with differentiation of cells into CD4
1CD8
1 double positive (DP)
thymocytes. TCR a-chain gene rearrangements then occur and
cells that express a functional but non self reactive a/b TCR
complex differentiate to either CD4
1 or CD8
1 single positive (SP)
T cells [1, 3, 36]. Figure 1C shows that LckCre
1LKB1
ﬂ/ﬂ thymi
contained mostly DN cells and had very few DP or SP. There were
also very few peripheral T cells present in the blood or spleen of
the LckCre
1LKB1
ﬂ/ﬂ mice compared to LckCre
1 LKB1
1/1 control
animals (Fig. 1D and E). Moreover, in the few peripheral T cells
of LckCre
1LKB1
ﬂ/ﬂ mice there was evidence that LKB1 deletion
was not complete, as cells contained non-deleted LKB1 ﬂoxed
alleles (Fig. 1F). Initial analysis of LckCre
1LKB1
ﬂ/ﬂ mice thus
showed that LKB1 is essential for T-cell development in the
thymus; only cells that fail to delete LKB1 can differentiate in the
thymus and generate peripheral T cells.
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DN thymocytes can be subdivided on the basis of CD44 and CD25
expression: the earliest progenitors are CD44
1and CD25
  DN1),
followed sequentially by the CD44
1 and CD25
1 (DN2), CD44
 
and CD25
1 (DN3) and CD44
 CD25
  DN4 ) populations [3, 36].
CD25 and CD44 staining proﬁles showed that LckCre
1LKB1
ﬂ/ﬂ
thymi had an increased frequency of the DN3 subset: numbers of
DN3 thymocytes were 4.0–9.1 10
6 in LckCre
1LKB1
1/1 while
3.6–7.6 10
6 in LckCre
1LKB1
ﬂ/ﬂ thymi (Fig. 2A). Moreover,
DN3 cells in LckCre
1LKB1
ﬂ/ﬂ thymi showed abnormally high
levels of CD25 expression (Fig. 2B). There was no subset of
cells corresponding to WT DN4, i.e. CD44
 CD25
  in LckCre
1
LKB1
ﬂ/ﬂ thymi although there was a population of CD44
 
CD25
low cells that resembled cells in transition from the DN3 to
DN4 stage. Numbers of DN4 thymocytes were 1.6–3.7 10
6 in
LckCre
1LKB1
1/1 thymi while the numbers of CD44
 CD25
low
thymocytes were 3.6–7.6 and 0.8–2.1 10
6 in LckCre
1LKB1
ﬂ/ﬂ
samples. The ﬁrst phenotypic difference between LckCre
1LKB1
ﬂ/ﬂ
and normal thymi is thus seen in DN3 thymocytes; some cells
partially transit to the DN4 stage albeit at lower frequency than
normal. The proximal p56Lck promoter is active in DN1 cells,
although its activation tends to be heterogeneous until the DN3
stage [37]. In this context, genomic PCR analysis indicated partial
deletion of LKB1 in DN3 cells and complete loss in the CD44
 
CD25
low cells (Fig. 2C).
LKB1 is known to phosphorylate and activate AMPK in
response to energy stress ([22, 38]. Therefore to assess functional
loss of LKB1, we compared the ability of 2-deoxyglucose, an
inhibitor of glycolysis that increases cellular ratios of AMP/ATP,
to activate AMPK in control and LckCre
1LKB1
ﬂ/ﬂ DN thymocytes.
AMPKa1 can also be phosphorylated and activated by calcium/
calmodulin dependent kinase kinases (CaMKK) in T cells [31] so
the effect of the CaMKK inhibitor STO609 on AMPK activation
was also examined. Figure 2D shows that there is low basal
phosphorylation of Thr 172 in the activation loop of AMPKa1i n
WT pre-T cells and that this phosphorylation is increased by 2-DG
treatment. AMPKa1 Thr 172 phosphorylation was not inhibited
by STO609. Basal phosphorylation of AMPKa1 in LckCre
1
LKB1
ﬂ/ﬂ thymocytes was observed, but this was not increased by
2-DG treatment.
LKB1 and pre-TCR/Notch signaling
CD25 downregulation in DN3 is driven by the pre-TCR [39]. The
high level of CD25 on LckCre
1LKB1
ﬂ/ﬂ DN3 cells coupled with
the failure of these cells to completely downregulate CD25 and
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Figure 1. Deletion of LKB1 prevents T-cell development (A) Appearance of thymi in LckCre
1LKB1
ﬂ/ﬂ and LckCre
1LKB1
1/1 mice. (B) Total thymocyte
numbers from 5- to 8-wk-old LckCre
1LKB1
ﬂ/ﬂ (n510) and LckCre
1LKB1
1/1 (n510) mice. (C) Flow cytometry of CD4 and CD8 subpopulations in
thymocytes from LckCre
1LKB1
ﬂ/ﬂ and LckCre
1LKB1
1/1 mice. Dot plots of Thy-1-gated cells are representative of ten independent experiments.
(D) Flow cytometry of T cell (TCRb
1) and B cell (B220
1) subpopulations in blood from LckCre
1LKB1
ﬂ/ﬂ and LckCre
1LKB1
1/1 mice. Dot plots
are representative of three independent experiments. Gates show T and B cell populations. (E) Total numbers of T lymphocytes in spleens from
LckCre
1LKB1
ﬂ/ﬂ (n55) and LckCre
1LKB1
1/1 (n55) mice. (F) Genomic PCR analysis of the ﬂ/ﬂ LKB1 gene in T lymphocytes from spleen indicating
that peripheral T cells have not deleted the LKB1 allele.
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pre-TCR expression or function. The rate-limiting step for pre-
TCR expression is normally the TCR b locus rearrangement [40].
However, analysis of intracellular TCR-b expression showed that
LckCre
1LKB1
ﬂ/ﬂ DN3 cells had successfully rearranged their
TCR-b locus and expressed intracellular TCR subunits at the
normal frequency (approximately 15%) (Fig. 3A). It was also
seen that the subpopulation of LKB1-null pre-T cells that had
partially downregulated CD25 were predominantly TCR-b
selected (80%) and in this regard were indistinguishable from
bona ﬁde WT DN4 (Fig. 3A).
One difference between WT and LKB1 deleted DN3 cells is
that the latter have increased expression of CD25, a phenotype
that frequently results from defective pre-TCR signal transduc-
tion. We therefore examined a range of pre-TCR-induced
responses in LckCre
1LKB1
ﬂ/ﬂ pre-T cells. One key function of the
pre-TCR is to drive cell cycle progression as cells transit from DN3
to DN4. Flow cytometric analysis of cellular DNA content showed
that LKB1 loss did not block cell cycle entry, as LKB1-null pre-T
cells can enter the proliferative S/G2 phases of the cell cycle
albeit at a reduced frequency compared to controls (Fig. 3B). Pre-
TCR signaling also induces expression of key nutrient receptors
on T-cell progenitors, namely CD71 the transferrin receptor and
CD98, a subunit of the L-aa transporter [7]. LKB1 loss had no
impact on surface expression of CD71 the transferrin receptor but
there was a striking decrease in the surface expression of CD98 aa
transporter in LckCre
1LKB1
ﬂ/f pre-T cells (Fig. 3C).
We also analyzed the effect of LKB1 deletion on pre-TCR-
induced phosphorylation (Ser235/236) of the S6 ribosomal
subunit by the 70kDa ribosomal S6 kinases. S6 phosphorylation
can be quantiﬁed directly ex vivo by ﬂow cytometry and intra-
cellular staining of ﬁxed cells with speciﬁc phospho-S6 antisera
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Figure 2. DN3/DN4 transition defects in LKB1-null thymocytes. (A) Flow cytometry of CD44 and CD25 surface expression in CD4
 CD8
  DN
thymocytes from LckCre
1LKB1
ﬂ/ﬂ and LckCre
1LKB1
1/1 thymi. CD25 and CD44 proﬁles of Thy-1
1 DN cells additionally gated to exclude cells from
the non-TCR lineage (lineage). Gates show DN1-DN4 populations, representative of ﬁve independent experiments. (B) Surface expression of CD25
in lineage Thy-1
1 thymocytes from LckCre
1LKB1
ﬂ/ﬂ and LckCre
1LKB1
1/1 mice, representative of ﬁve independent experiments. (C) Genomic PCR
analysis of the LKB1 gene in DN3 and CD44
 CD25
low thymocytes. Top, PCR ampliﬁcation of the gene product produced only when the LKB1 ﬂoxed
allele is deleted in Lck-Cre
1 thymocytes. Bottom, PCR ampliﬁcation of the non-deleted LKB1 gene. The upper bands represent the PCR product
generated from the LKB1 non-deleted ﬂoxed gene, while the lower band indicates the WT LKB1 gene. (D) LckCre
1LKB1
ﬂ/ﬂ CD44
 CD25
low
thymocytes and LckCre
1LKB1
1/1 DN4 thymocytes were either untreated or pretreated with STO-609 and then stimulated with 50mM
2-deoxyglucose for 5min. Western blot of cell lysates prepared from these thymocytes with pThr-172–AMPK and AMPK a1 antisera, representative
of three independent experiments.
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Figure 3. PreTCR and Notch signaling in LKB1-null thymocytes (A) Intracellular TCRb expression in DN3 and DN4 thymocytes of LckCre
1LKB1
1/1 and
DN3 and CD44
 CD25
low thymocytes of LckCre
1LKB1
ﬂ/ﬂ mice. (B) Flow cytometry of cellular DNA content (gated on live cells) of DN4 thymocyte from
LckCre
1LKB1
1/1 and CD44
 CD25
low thymocytes from LckCre
1LKB1
ﬂ/ﬂ mice. The numbers indicate percentage of cells in S1G2/M phases of the cell
cycle, representative of three independent experiments. (C) Data show CD98 and CD71 surface expression on DN4 thymocytes from LckCre
1LKB1
1/1
a n do nC D 4 4
 CD25
low thymocytes from LckCre
1LKB1
ﬂ/ﬂ mice, representative of three independent experiments. (D) Histograms show Ser 235/236 S6
ribosomal protein phosphorylation in DN3 and DN4 thymocytes from LckCre
1LKB1
1/1and in DN3 and CD44
 CD25
low thymocytes from LckCre
1
LKB1
ﬂ/ﬂ mice, representative of three independent experiments. (E) Quantitative RT-PCR examining the expression levels of CD2, CD5, Nur77, Hes1
and Deltex1 mRNA in DN4 thymocytes of LckCre
1LKB1
1/1 (n53) and CD44
 CD25
low thymocytes from LckCre
1LKB1
ﬂ/ﬂ (n55) mice. Expression was
normalized to the mRNA levels in LKB
1/1 Lck-Cre
1 DN4 thymocytes; data show mean7SD. Differences in CD2 and CD5 expression are considered to
be signiﬁcant (p50.035 and p50.036 for CD2 and CD5, respectively, p50.1 for Nur77).
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heterogeneous for phosphoS6: the majority of cells are phos-
phoS6
low but 15–20% are phosphoS6
high corresponding to cells
that have rearranged their TCR-b subunit to express the pre-TCR.
DN4 thymocytes are primarily phosphoS6
high (Fig. 3D). The data
show severely reduced phosphorylation of S6 in LckCre
1LKB1
ﬂ/ﬂ
stained DN thymocytes. S6 phosphorylation is induced by
PDK1/PKB signaling pathways initiated by the pre-TCR and
sustained by stromal signals such as Notch ligands [41]. In this
respect, LKB1-null T cells had normal expression of CD71, the
transferrin receptor. This is relevant because CD71 expression in
T-cell progenitors is controlled by pre-TCR/Notch-induced PDK1/
PKB-mediated pathways [7]. The normal expression of CD71 is
thus evidence for functioning PKB signaling in LKB1-null pre-
T cells. We further explored the impact of LKB1 on pre-TCR
signaling by examining expression of known pre-TCR-induced
genes, such as CD2 and CD5 and Nurr77 [7, 42, 43]. LKB1-null
DN4 pre-T cells expressed lower levels of CD2 mRNA than
controls and there was also a small but reproducible decrease in
expression of CD5 mRNA. However, the expression of Nur77, also
a pre-TCR-induced gene, was not changed (Fig. 3E). The results
argue that LKB1 loss causes selective defects but not global
problems with pre-TCR signal transduction. We also examined
the expression of Notch target genes, Hes-1 and Deltex-1[44], in
pre-T cells isolated ex vivo from control or LckCre
1LKB1
ﬂ/ﬂ mice.
The CD44
 CD25
low cells from LckCre
1LKB1
ﬂ/ﬂ mice expressed
increased levels of Hes-1 and Deltex1 when compared with
control cells (Fig. 3E). The expression of these Notch target genes
in LKB1-null pre-T cells argues that these cells are responding to
Notch ligands in vivo.
LKB1 is required for survival of TCR-b selected T-cell
progenitors
The differentiation and proliferation of b selected pre-T cells in
the thymus is dependent on sustained Notch receptor/ligand
interactions [8, 41, 45]. To explore further impact of LKB1
deletion on thymocyte development, we compared the responses
of pre-T cells from control or LckCre
1LKB1
ﬂ/ﬂ mice in an in vitro
system that uses OP9 stromal cells expressing the Notch ligand
delta-like 1 (OP9-DL1) and IL-7 to support survival, proliferation
and differentiation of T-cell progenitors [46]. In initial experi-
ments we compared the responses of cells maintained on the
OP9-DL1 cells in both the presence and absence of IL-7. As
described previously, normal DN thymocytes (LckCre
1LKB1
1/1)
undergo proliferative expansion when cultured on OP9-DL1 cells
and this proliferative response is enhanced by the addition
of IL-7 [47] (Fig. 4A). In contrast, LKB1-null DN thymocytes
(LckCre
1LKB1
ﬂ/ﬂ) did not proliferate on OP9-DL1 cells. The
addition of IL-7 to the cultures caused a small improvement to the
proliferative response of the LKB1-null DN thymocytes, indicating
that the cells had not lost the capacity to respond to IL-7 but the
cells still failed to undergo proliferative expansion in these in
vitro models. Moreover, the proliferative expansion of normal
TCR-b selected DN4 (LckCre
1LKB1
1/1) is followed by their
differentiation to DP thymocytes. Strikingly, TCR-b selected
CD44
 CD25
lowLckCre
1LKB1
ﬂ/ﬂ thymocytes do not differentiate
to DP on OP9-DL1 cells (Fig. 4B), in fact they die. LKB1-null pre-
T cells thus rapidly acquire the light scattering proﬁles of dead
cells rather than viable cells (Fig. 4C). LKB1-null pre-T cells also
show a rapid decrease in plasma membrane integrity (Fig. 4D)
and a high frequency of cells with a sub-G1 DNA content,
indicative of DNA degradation (Fig. 4E). LKB1 is thus essential
for the survival of TCR-b selected T-cell progenitors as they
proliferate and differentiate in response to Notch ligands and
IL-7.
LKB1 is required for survival of proliferating peripheral
T cells
Does this requirement for LKB1 support the proliferation of T-cell
progenitors unique to this T-cell subpopulation? To address this
question we examined the LKB1 requirement for the proliferative
responses of mature T cells. In these experiments we bypassed the
LKB1 requirement for T-cell development by breeding mice
expressing LKB1 ﬂoxed alleles to CreER
T2 mice that express a
tamoxifen inducible Cre recombinase. In initial experiments,
CreER
T2LKB1
1/1 and CreER
T2LKB1
ﬂ/ﬂ peripheral T cells were
polyclonally activated with CD3 Ab and maintained in exponential
proliferation in vitro by the addition of IL-2. T cells were then
treated with 4-hydroxytamoxifen (4OHT) to induce deletion of
LKB1 in the CreER
T2LKB1
ﬂ/ﬂ cells. The data (Fig. 5A) conﬁrmed
deletion of LKB1 following 4OHT treatment of CreER
T2LKB1
ﬂ/ﬂ
peripheral T lymphoblasts and revealed that LKB1 deletion
stopped the proliferation of T cells and resulted in cell death
(Fig. 5B and C). In further experiments, peripheral primary T cell
isolated from CreER
T2LKB1
1/1 and CreER
T2LKB1
ﬂ/ﬂ mice were
cultured in IL-7 in the presence of 4OHT. Thereafter cells were
stimulated with CD3/CD28 Ab coated beads to induce prolifera-
tion. The data in Fig. 5D show that 4OHT treated control
lymphocytes from CreER
T2 mice (CreER
T2LKB1
1/1) gave a robust
proliferative response following CD3/CD28 stimulation whereas
CreER
T2LKB1
ﬂ/ﬂ T cells did not. Both cell populations could be
maintained with comparable viability when cultured in IL-7
(Fig. 5E) but the viability of the CD3/CD38 triggered LKB1-null
cells were markedly reduced compared with the control LKB1
WT cells (Fig. 5E). These data show that LKB1 is required to
support the survival of mature T cells when they are induced to
proliferate.
Discussion
The present results establish that LKB1 has critical functions
during T-cell development. In the thymus LKB1 is required for the
survival and differentiation of TCR-b selected T-cell progenitors.
T-cell progenitors that successfully rearrange their TCR-b and
express the pre-TCR complex normally proliferate rapidly prior to
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present data now show that LKB1-null pre-T cells that have
rearranged their TCR-b locus are unable to proliferate and
undergo cell death rather than complete their normal program of
development. The data also show that LKB1-null peripheral
T cells are unable to proliferate and undergo cell death in
response to CD3/CD28 stimulation. Activated T cells maintained
in culture with IL-2 similarly fail to proliferate and die following
LKB1 loss. It is well established that cells that fail to match energy
production to energy demands die by apoptosis. LKB1 thus
appears to coordinate the ability of T cells to match energy
production to the energy requirements for the proliferative burst
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Figure 4. LKB1 is required for survival of TCRb selected T-cell progenitors A) DN thymocytes from LckCre
1LKB1
1/1 (n53) and LckCre
1LKB1
ﬂ/ﬂ
(n53) mice were co-cultured with OP9-DL1 stromal cell monolayers. Cells were either stimulated with IL-7 or left untreated. Data show the
mean fold increase in cell number following 5 days culture7SD. Differences in the proliferation of LckCre
1LKB1
1/1 and LckCre
1LKB1
ﬂ/ﬂ DN
thymocytes are considered to be signiﬁcant (p50.007 without IL-7 and p50.0005 in the presence of IL-7, respectively). The IL-7-induced
proliferation of LckCre
1LKB1
ﬂ/ﬂ DN thymocytes is also signiﬁcant, p50.004. (B) DN thymocytes from LckCre
1LKB1
1/1 and CD44
 CD25
low
thymocytes from LckCre
1LKB1
ﬂ/ﬂ mice were co-cultured with OP9-DL1 stromal cell monolayers and treated with IL-7. The surface expression of
CD4 and CD8 on thymocytes and the cell number were analyzed after 5 days of co-culture, representative of three independent experiments.
C) DN4 thymocytes from LckCre
1LKB1
1/1 and CD44
 CD25
low thymocytes from LckCre
1LKB1
ﬂ/ﬂ mice were co-cultured with OP9-DL1. Flow
cytometric analysis of forward and side scatter after 18 and 60h of co-culture, respectively. (D) DN4 thymocytes from tamoxifen LckCre
1LKB1
1/1
and CD44
  CD25
low thymocytes from LckCre
1LKB1
ﬂ/ﬂ mice were co-cultured with OP9-DL1 for 18h, and stained with Thy1 and
7-aminoactinomycin D to investigate cell death. The numbers indicate the percentage of dead thymocytes. E) DN4 thymocytes from LckCre
1
LKB1
1/1 and CD44
  CD25
low thymocytes from LckCre
1LKB1
ﬂ/ﬂ mice were co-cultured with OP9-DL1 stromal cell monolayers. The data show the
DNA content of DN4 thymocytes (not gated, total thymocyte population) after 18h of co-culture. The numbers show the percentage of cells with
degraded DNA.
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cytokine-induced proliferation of peripheral T cells.
LKB1 phosphorylates and activates multiple members of
the AMPK family including the a1 and a2 isoforms of AMPK,
NUAK1-2, BRSK1-2, QIK, QSK, SIK, MELK and MARK1–4 kinases
[21]. There have been some studies to probe the role of indivi-
dual members of this kinase family in T cells. For example, AMPK
a1-null T cells have increased sensitivity to energy stress [32] and
there are defects in immune homeostasis in mice that lack
expression of another AMPK family kinase, MARK2/Par-1b [33].
However, neither the AMPK a1 nor MARK2 mice showed any
evidence for defective thymus development [32, 33]. This could
mean that there is redundancy between members of the AMPK
family in T cells. In this respect, redundancy between different
serine/threonine kinases has been seen previously in T lympho-
cytes. For example, T cells express three isoforms of PKB/Akt and
unveiling of the function of these kinases in vivo in the thymus
required simultaneous deletion of all three isoforms [48]. There
is also redundancy between different isoforms of PI3K in T-cell
progenitors such that deletion of both the p110 delta and p110
gamma catalytic subunits of PI3K is required to reveal the
importance of PI3K in T-cell progenitors [49]. The impact of
LKB1 deletion versus deletion of individual AMPK family kinases
is an indication that there is similar redundancy between differ-
ent members of the AMPK family in T cells.
Previous studies have focused extensively on the role of PI3K
and the serine/threonine kinases PKB/Akt in the control of T-cell
metabolism [50].The present data showing that LKB1, a kinase
that evolved to couple energy metabolism and cell differentiation,
also has essential functions in T lymphocytes. It reveals that
T cells use multiple pathways to deal with the metabolic stress of
proliferation. Here it is important to note that these two kinase
pathways function in quite different modes. In T cells, PKB/Akt
activity is controlled directly by Ag receptors/costimulatory
molecules and or cytokines and the level of Akt activity is
determined by cellular levels of Phosphatidyinositol (3,4,5) tris
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Figure 5. LKB1 is required for survival of proliferating peripheral T cells. (A) LKB1 Western blot of cell lysates from CreER
T2LKB1
ﬂ/ﬂ mouse
T lymphoblasts either treated or not with 0.4mM 4-hydroxytamoxifen for 3 days. (B) Fold increase in cell number of T lymphoblasts from CreER
T2
LKB1
1/1 and CreER
T2LKB1
ﬂ/ﬂ mice. The cells were treated with 0.4mM 4-hydroxytamoxifen for 3 days prior to the start of analyses. Data show
mean7SD. Differences in the proliferation of LckCre
1LKB1
1/1 and LckCre
1LKB1
ﬂ/ﬂ lymphoblasts are considered to be signiﬁcant (p50.001 at 24h
and p50.0005 at 48h). (C) Percentage of dead cells (based on FSC/SSC proﬁle) in the 4-hydroxytamoxifen treated T lymphoblast cultures
from CreER
T2LKB1
1/1 and CreER
T2LKB1
ﬂ/ﬂ mice. The data corresponds to the 48h time point in Fig. 5B. Data show mean7SD. Differences between
LckCre
1LKB1
1/1 and LckCre
1LKB1
ﬂ/ﬂ samples are considered to be signiﬁcant (p50.003). (D) Primary T cells from CreER
T2LKB1
1/1 and
CreER
T2LKB1
ﬂ/ﬂ mice were either treated with IL-7 or stimulated with CD3/CD28 Ab-coated beads. The cells were treated with 0.6mM
4-hydroxytamoxifen for 4 days prior to stimulation. Data show fold increase in cell number following 2 days of stimulation. Data show mean7SD.
Differences between CD3/CD28 stimulated LckCre
1LKB1
1/1 and LckCre
1LKB1
ﬂ/ﬂ cells are considered to be signiﬁcant (p50.002). For IL-7 treated
samples, p50.15. (E) Naı ¨ve T cells from CreER
T2LKB1
1/1 and CreER
T2LKB1
ﬂ/ﬂ mice were either treated with IL-7 or stimulated with CD3/CD28 Ab-
coated beads. The cells were treated with 0.6mM 4-hydroxytamoxifen for 4 days prior to the stimulation. Data shows the percentage of dead cells
(based on FSC/SSC proﬁle) following 2 days of stimulation. Data show mean7SD. Differences between CD3/CD28 stimulated LckCre
1LKB1
1/1 and
LckCre
1LKB1
ﬂ/ﬂ cells are considered to be signiﬁcant (p50.00004). For IL-7 treated samples, p50.3.
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target of rapamycin) [51]. In contrast, LKB1 signaling pathways
are not coupled directly to extracellular stimuli but rather act
homeostatically in response to energy stress to restore energy
balance. For example, LKB1 acts as a rheostat for cellular AMP/
ATP ratios and phsophorylates and activates AMPK when cellular
levels of ATP drop. This concept of how LKB1 works explains why
it is not possible to explain the phenotype of LKB1-null T cells by
the loss of a linear biochemical signaling pathway that is coupled
to a single receptor. Rather LKB1 is integral to the control of
T-cell proliferation irrespective of the proliferative stimulus.
Materials and Methods
Mice
Mice (5–7 weeks old) were maintained in SPF conditions at the
University of Dundee under Home Ofﬁce project license PPL60/
3116. C57BL/6-Gt(ROSA)26Sor tm9(cre/Esr1)Arte mice
carrying a transgene in the ROSA locus encoding for a
ubiquitously expressed Cre recombinase/modiﬁed oestrogen
receptor fusion protein CreER
T2, were purchased from Taconic-
Artemis. LKB1
ﬂ/ﬂ mice were generated and bred as previously
described [34]. LKB1
ﬂ/ﬂ mice were crossed either to transgenic
mice expressing Cre recombinase under the T-cell-speciﬁc Lck
promoter [35] or to CreER
T2 mice. Genotyping was performed by
PCR using genomic DNA isolated from ears. The presence
of a WT or ﬂoxed LKB1 allele was detected using two
primers: 50-CCAGCCTTCTGACTCTCAGG-30 and 50-GTAGG-
TATTCCAGGCCGTCA-30. PCR ampliﬁcation of the WT or the
ﬂoxed LKB1 alleles resulted in 200-bp and 250-bp PCR products,
respectively. For the detection of Cre (either LckCre or CreER
T2),
the following primers were employed: 50-AAATGGTTTCCCGCA-
GAACC-30 and 50-TAGCTGGCTGGTGGCAGATG-30. Cre-mediated
deletion of the ﬂoxed LKB1 allele was proved by PCR
using primers: 50-CAGGTTCAGCAGAATCAC-30 and 50-GGGAA-
GAAGGCGATATAAGG-30.
Flow cytometric analysis
Characterization of different thymocyte subpopulations was
performed as described previously [7]. Brieﬂy, Ab conjugated
to ﬂuorescein isothiocyanate, phycoerythrin, allophycocyanin
and biotin were obtained from either Pharmingen (San Diego,
CA, USA) or eBioscience (San Diego, CA, USA). TriColour-
conjugated Ab were obtained from Caltag (Burlingame, CA,
USA). Cells were stained for surface expression of the following
markers using the Ab in parentheses: CD4 (RM4-5), CD8 (53-
6.7), CD25 (7D4), CD44 (IM7), CD98 (RL388), CD71 (C2),
Thy1.2 (53-2.1), TCR-b (H57-597), B220 (RA3-6B2) and
TCR/ (GL3). Cells were stained with saturating concentrations
of Ab in accordance with the manufacturer’s instructions.
Data were acquired on either a FACS Calibur (Becton Dickinson,
Franklin Lakes, NJ, USA) or a LSR1 ﬂow cytometer (Becton
Dickinson) using CellQuest software and were analyzed
using either CellQuest (Becton Dickinson) or FlowJo (Treestar,
San Carlos, CA, USA) software. Viable cells were gated
according to their forward scatter and side scatter proﬁles.
CD4
  and CD8
  DN subsets were gated by lineage exclusion
(lineage) of all CD4
1, CD8
1 DP and SP cells and TCR-g
1. DN3
and DN4 were further deﬁned as CD25
1CD44
  and
CD25
 CD44
  thymocytes, respectively. Mature SP thymocytes
were deﬁned as Thy-1
1, TCR-b
hi and positive for either CD4
or CD8 expression. Cell death was analyzed by staining with
7-aminoactinomycin D (5mg/mL).
Cell Puriﬁcation
DN3 and DN4 thymocytes were puriﬁed by ﬁrst depleting thymic
populations of CD4
1 and CD8
1 cells using an AutoMACs
magnetic cell sorter (Miltenyi Biotech, Auburn, CA, USA) before
sorting to a purity greater than 95%, using a FACS VantageSE cell
sorter (Becton Dickinson). Peripheral T lymphocyes (from
spleen) were puriﬁed by AutoMACS magnetic cell sorter
(Miltenyi Biotech) using mouse pan T-cell isolation kit.
Intracellular TCR-b staining
Intracellular TCR-b staining was performed as described previously
[10]. Brieﬂy: thymocytes were stained for cell surface markers to
deﬁne DN3 and DN4 subsets. After ﬁxation in 1% paraformaldehyde
for 10min at 251C, cells were washed in PBS and permeabilized for
10min at room temperature in saponin buffer (0.5% (weight/
volume) saponin, 5% FBS and 10mM HEPES, pH 7.4, in PBS)
Permeabilized cells were incubated for 45min with phycoerythrin-
conjugated Ab to TCR in saponin buffer, were washed in saponin
buffer and were analyzed on a FACS Calibur. Cell surface binding
sites were blocked by biotinylated TCR and the speciﬁcity of staining
was controlled by parallel staining with phycoerythrin-conjugated
isotype-matched control Ab (Armenian hamster IgG2).
Intracellular phospho-S6 staining
Intracellular phosphoS6 staining was performed as described
previously [10]. Thymocytes were treated with 20nM rapamycin
or were left untreated for 20min at 371C. Treatment of cells
with rapamycin inhibits the activity of mTor and rapidly reverses S6
(Ser 235/236) phosphorylation. Phospho-S6 staining of rapamycin-
treated cells thus provides an internal negative control as
a standard for each sample. Cells were washed and stained with
surface markers to deﬁne the DN3 and DN4 subsets, then were ﬁxed
in 0.5% paraformaldehyde for 15min at 371C, followed by 15min
in 90% methanol on ice. After ﬁxation, cells were washed twice in
BSA buffer (0.5% BSA in PBS), then blocked for 10min at 251Ci n
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phospho-S6 (2211; Cell Signaling Technologies) in BSA buffer, then
were washed and incubated for 30min at 251Cw i t hF I T C -
conjugated donkey IgG Ab to rabbit (Jackson ImmunoResearch).
Samples were washed in BSA buffer and were analyzed on a FACS
Calibur.
Cell cycle analysis
The cellular DNA content of DN3 and DN4 thymocytes was
analyzed on live cells, with Hoechst-33342 (Molecular Probes)
staining. Cells were incubated for 1h at 371Ci n5mg/mL Hoechst-
33342 in 2% FBS DMEM and then were surface stained for CD25,
Thy-1 and lineage markers (including CD44). Samples were
analyzed on an LSR1 ﬂow cytometer eliminating doublets from
the analysis.
Quantitative RT-PCR
DN3 and DN4 Cells (0.5 10
6 per sample) were lysed for RNA
isolation using the QIAshredder homogenizer (QIAGEN). RNA was
puriﬁed with the RNeasy Mini, RNA isolation kit (QIAGEN)
following the manufacturer’s protocol and including an on-column
DNase digestion step with the RNase-free DNase set (QIAGEN).
cDNA was generated using the iScript
TM cDNA synthesis kit (BIO-
RAD). Real-time PCR reactions were performed in a 20mLm i x t u r e
containing 1  iQ
TM SYBR Green supermix (BIO-RAD), 1mLo f
cDNA preparation and 0.4mM forward and reverse primers. Real-
time quantitations were performed using the BIO-RAD iCycler iQ
system and using 18S rRNA as an internal control. The primer
sequences for the PCR were as follows
Hes1 Forward 50-ACCTTCCAGTGGCTCCTC-30
Reverse 50-TTTAGTGTCCGTCAGAAGAGAG-30
CD2 Forward 50-GTATGAGGTCTTAGCAAACGGATC-30
Reverse 50-TGTGCCATACACCATTACATTATAGG-30
Nur77 Forward 50-CCTGTTGCTAGAGTCTGCCTTC-30
Reverse 50-CAATCCAATCACCAAAGCCACG-30
Deltex1 Forward: 50-CTTCTGCTACCTCATCTACTTCAA-30
Reverse: 50-GGAATGGAGCCGACAGTGAG-30
18S Forward 50-ATCAGATACCGTCGTAGTTCCG-30
Reverse 50 TCCGTCAATTCCTTTAAGTTTCAGC-30
Cell culture
OP9 bone marrow stromal cells expressing OP9-DL1 and control
OP9 cells were a gift from Juan Carlos Zu ´n ˜iga-Pﬂu ¨cker (Toronto,
Canada) [46]. OP9 cells were maintained in aMEM supplemented
with 50mM 2-mercaptoethanol, 100U/mL penicillin, 1mg/mL
streptomycin and 20% heat-inactivated FBS. DN thymocytes were
co-cultured on OP9-DL1 monolayers for times indicated in ﬁgure
legends in the presence or absence of 5ng/mL of IL-7 as indicated.
For harvesting, thymocytes were ﬁltered through 50mmﬁ l t e r st o
remove OP9-DL1 cells before developmental progression of
T lineage cells was assessed. For activation of primary T cells
spleens or lymph nodes were removed from CreER
T2LKB1
1/1 and
CreER
T2LKB1
ﬂ/ﬂ mice, disaggregated and red blood cells were lysed.
Cells were cultured in RPMI-1640 medium containing L-glutamine
(Invitrogen), 10% v/v heat-inactivated FBS (Gibco), 50mM
b-mercaptoethanol (Sigma) and penicillin–streptomycin (Gibco).
Single-cell suspensions from lymph node preparations
cultured at 5 10
6 cells per mL. Cells were treated with 0.6mM
4OHT in the presence of 5ng/mL IL-7 for 4 days. Thereafter cells
were either stimulated with CD3/CD28 Ab-coated beads (Dyna-
beads Mouse CD3/CD28T cell expander, Invitrogen) or left in
5ng/mL IL-7 for 3 days.
For the generation of lymphoblasts, mouse CD8
1 T cells were
cultured for 48h in the presence of a CD3 Ab (5mg/mL; 145-
2C11; R&D Systems) to trigger the TCR. Thereafter the cells were
washed and maintained in exponential proliferation with 20ng/
mL IL-2 (Chiron) for another 2 days. Then the cells were treated
with 0.4mM 4OHT for 3 days. The 4OHT was washed and the cell
proliferation was investigated in the presence of IL-2.
Western blot analysis
Sorted DN4 thymocytes or peripheral T lymphoblasts were lysed
on ice in NP-40 lysis buffer (50mM HEPES (pH 7.4), 75mM
NaCl, 1% Nonidet P-40, 10mM sodium ﬂuoride, 10mM
iodoacetamide, 1mM EDTA, 40mM b-glycerophosphate,
protease inhibitors, 100mM sodium orthovanadate). Lysates were
centrifuged at 1600 g for 15min at 41C. Protein samples were
separated by SDS NuPAGE 4–12% Bis-Tris PAGE (Invitrogen)
transferred to nitrocellulose membrane and detected by Western
blot analysis using standard techniques. The phosphorylated
AMPK (phospho-172Thr-AMPK Rabbit mAb (Cell Signaling
Technology) and a1 AMPK antisera were used as described
[31]. The LKB1 Ab from Cell Signaling Technology was used to
probe for LKB1 expression.
Statistical analysis
Statistical analyses were performed using GraphPad Prism 4.00
for Macintosh, GraphPad Software. A non-parametric
Mann–Whitney test was used where the number of experiments
performed was not sufﬁcient to prove normal distribution. When
comparing gene expression between LckCre
1LKB1
1/1 and
LckCre
1LKB1
ﬂ/ﬂ animals, a Student’s t-test was used with the
theoretical mean of LckCre
1LKB1
1/1 sample set to 1. Differences
were considered as signiﬁcant if p o 0.05.
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